Pure Biologics Spólka Akcyjna (PUR) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.011x

Based on the latest financial reports, Pure Biologics Spólka Akcyjna (PUR) has a cash flow conversion efficiency ratio of 0.011x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł-216.00K ≈ $-59.45K USD) by net assets (zł-19.39 Million ≈ $-5.34 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Pure Biologics Spólka Akcyjna stock valuation for the company's overall valuation and market capitalisation.

Pure Biologics Spólka Akcyjna - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Pure Biologics Spólka Akcyjna's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Pure Biologics Spólka Akcyjna Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pure Biologics Spólka Akcyjna ranked by their cash flow conversion efficiency. Explore PUR cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Toyo Ventures Holdings Bhd KLSE:7173	0.099x
Batero Gold Corp V:BAT	-0.003x
Moatable Inc NYSE:MTBLY	0.025x
BEDFORD METALS CORP. F:O8D	N/A
One Click Group Ltd AU:1CG	0.181x
Courtois S.A PA:COUR	-0.010x
Korporacja Gospodarcza efekt S.A WAR:EFK	-0.094x
Snipp Interactive Inc V:SPN	-0.018x

Annual Cash Flow Conversion Efficiency for Pure Biologics Spólka Akcyjna (2016–2024)

The table below shows the annual cash flow conversion efficiency of Pure Biologics Spólka Akcyjna from 2016 to 2024. View latest Pure Biologics Spólka Akcyjna stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	zł-13.12 Million ≈ $-3.61 Million	zł-10.83 Million ≈ $-2.98 Million	0.826x	+106.72%
2023-12-31	zł1.89 Million ≈ $520.98K	zł-23.26 Million ≈ $-6.40 Million	-12.288x	-1193.16%
2022-12-31	zł18.30 Million ≈ $5.04 Million	zł-17.39 Million ≈ $-4.79 Million	-0.950x	-56.11%
2021-12-31	zł39.49 Million ≈ $10.87 Million	zł-24.04 Million ≈ $-6.61 Million	-0.609x	-229.88%
2020-12-31	zł-2.89 Million ≈ $-794.54K	zł-1.35 Million ≈ $-372.37K	0.469x	-36.63%
2019-12-31	zł7.21 Million ≈ $1.99 Million	zł5.33 Million ≈ $1.47 Million	0.740x	+166.02%
2018-12-31	zł2.22 Million ≈ $611.22K	zł-2.49 Million ≈ $-684.71K	-1.120x	+91.75%
2017-12-31	zł209.77K ≈ $57.73K	zł-2.85 Million ≈ $-784.16K	-13.583x	-496.09%
2016-12-31	zł311.70K ≈ $85.78K	zł-710.24K ≈ $-195.47K	-2.279x	--

About Pure Biologics Spólka Akcyjna

WAR:PUR Poland Biotechnology

Market Cap

$8.33 Million

zł30.25 Million PLN

Market Cap Rank

#27602 Global

#301 in Poland

Share Price

zł2.67

Change (1 day)

-1.48%

52-Week Range

zł1.42 - zł7.00

All Time High

zł142.00